PocDoc has secured a CE mark for its AI driven digital reader of lateral flow tests. The cloud-based system allows any smartphone or tablet to become a digital reader of lateral flow tests and has been recorded as having over 98% accuracy. The COVID-19 pandemic highlighted the value of using lateral flow testing at scale and PocDoc's platform is a cost-effective solution to digitise and verify the test results, store the data, and integrate it back into healthcare systems with full end-to-end traceability so it can be analysed and acted upon in real-time. PocDoc's platform and accompanying smartphone app will allow any healthcare organisation to roll out lateral flow testing for any disease or marker at scale. This technology has huge applications in the developing world where the nearest pathology lab could be thousands of miles away from localised disease outbreaks.